Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Clinical and Experimental Immunology
|
November 11, 1999
A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methods
A M Deakin, K Singh, J S Crowe, et al.
Pharmacogenetics
|
November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer
D E Bamber, A A Fryer, R C Strange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
D R Ferry, M Deakin, J Baddeley, et al.
European Journal of Pharmacology
|
March 5, 2013
Characterization of selective Calcium-Release Activated Calcium channel blockers in mast cells and T-cells from human, rat, mouse and guinea-pig preparations
Louise V Rice, Heather J Bax, Linda J Russell, et al.
Digestive Surgery
|
November 19, 2005
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial
C Bassi, D D Stocken, A Olah, et al.
Carcinogenesis
|
April 1, 1996
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
M Deakin, J Elder, C Hendrickse, et al.
The Journal of Biological Chemistry
|
August 13, 2013
Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocket
John D Harling, Angela M Deakin, Sébastien Campos, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy
Catherine M Alder, Martin Ambler, Amanda J Campbell, et al.
Annals of Surgery
|
December 1, 2001
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
J P Neoptolemos, D D Stocken, J A Dunn, et al.
Journal of Medicinal Chemistry
|
August 25, 2015
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease
Kenneth Down, Augustin Amour, Ian R Baldwin, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Clinical and Experimental Immunology
|
November 11, 1999
A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methods
A M Deakin, K Singh, J S Crowe, et al.
Pharmacogenetics
|
November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer
D E Bamber, A A Fryer, R C Strange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
D R Ferry, M Deakin, J Baddeley, et al.
European Journal of Pharmacology
|
March 5, 2013
Characterization of selective Calcium-Release Activated Calcium channel blockers in mast cells and T-cells from human, rat, mouse and guinea-pig preparations
Louise V Rice, Heather J Bax, Linda J Russell, et al.
Digestive Surgery
|
November 19, 2005
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial
C Bassi, D D Stocken, A Olah, et al.
Carcinogenesis
|
April 1, 1996
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
M Deakin, J Elder, C Hendrickse, et al.
The Journal of Biological Chemistry
|
August 13, 2013
Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocket
John D Harling, Angela M Deakin, Sébastien Campos, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy
Catherine M Alder, Martin Ambler, Amanda J Campbell, et al.
Annals of Surgery
|
December 1, 2001
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
J P Neoptolemos, D D Stocken, J A Dunn, et al.
Journal of Medicinal Chemistry
|
August 25, 2015
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease
Kenneth Down, Augustin Amour, Ian R Baldwin, et al.
Page
of 9